[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356588-105":59,"doc-detail-356588-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-the-predicting-risk-of-ischemic-stroke-in-malignancy-estimation-tool","Development and Validation of the Predicting Risk of Ischemic Stroke in Malignancy Estimation Tool","","This study develops and validates the PRIME (Predicting Risk of Ischemic Stroke in Malignancy Estimation) tool to identify patients with newly diagnosed cancer at highest risk of ischemic stroke within 1 year. Using linked clinical and administrative data, a population-based retrospective cohort from Ontario, Canada (2010–2021) was split into derivation and validation cohorts. The final model used multivariable Fine-Gray regression with competing risk mortality, achieving good discrimination (C statistic 0.73) and good calibration. PRIME is implemented as an online calculator.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-the-predicting-risk-of-ischemic-stroke-in-malignancy-estimation-tool/356588/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-the-predicting-risk-of-ischemic-stroke-in-malignancy-estimation-tool/356588.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was the PRIME tool developed for patients with newly diagnosed cancer?","Question",{"text":112,"@type":113},"The risk of ischemic stroke is highest in the first year after a new cancer diagnosis, yet no existing tools could identify patients at highest risk. PRIME was created to fill this gap.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prediction model derived and validated?",{"text":117,"@type":113},"Researchers conducted a population-based retrospective cohort study and randomly assigned patients to prediction model derivation (60%) or validation (40%). Performance was assessed using discrimination (C statistic) and calibration plots.",{"name":119,"@type":110,"acceptedAnswer":120},"What performance did PRIME show for predicting 1-year ischemic stroke?",{"text":121,"@type":113},"The model showed good discrimination with a C statistic of 0.73 and was well calibrated, with points following the desired 45-degree line.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356588,1790143515,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Journal of the American Heart Association  \nORIGINAL RESEARCH  \n\n| Development and Validation of the Predicting Risk of Ischemic Stroke in Malignancy Estimation Tool\u003Cbr>Ronda Lun  , MD, MSc; Jenneke Leentjens  , MD; Joshua O. Cerasuolo  , MSc; David Kirkwood  , MSc; Moira K. Kapral  , MD, MSc; Marc Carrier  , MD, MSc; Deborah Siegal  , MD, MSc*; Rinku Sutradhar, PhD*\u003Cbr>BACKGROUND: The risk of ischemic stroke is highest during the first year following a new diagnosis of cancer, but no tools exist to identify patients at highest risk.\u003Cbr>METHODS: Using linked clinical and administrative databases, we conducted a population-based retrospective cohort study of adults in Ontario, Canada, with newly diagnosed cancer from 2010 to 2021. Patients were randomly selected for prediction model derivation (60%) or validation (40%) . The final model predicting ischemic stroke within 1 year following cancer diagnosis was derived using multivariable Fine-Gray regression with candidate predictors selected via backward elimination. Subdistribution-adjusted hazard ratios and 95% CIs were calculated, where all-cause mortality was treated as a competing event. Performance of the prediction model was assessed in the validation cohort based on the C statistic and calibration plots for discrimination and calibration, respectively.\u003Cbr>RESULTS: There were 698 566 eligible patients, with 418 911 in the derivation cohort and 279 576 in the validation cohort. The overall rate of stroke per 1000 person-years was 6.7 (95% CI, 6.4–6.9) . The final model included 22 predictors, including age, sex, demographic factors, cancer characteristics, and treatment characteristics. Discrimination was good, with a C statistic of 0.73. The model was well calibrated, with points following the desired 45-degree line.\u003Cbr>CONCLUSIONS: We derived and validated the PRIME (Predicting Risk of Ischemic Stroke in Malignancy Estimation) tool with good discrimination for ischemic stroke in patients with a new cancer diagnosis. The model was built into an online calculator ([https://study.ohri.ca/PRIME/](https://study.ohri.ca/PRIME/)) and has the potential to stratify patients with cancer based on their risk of stroke within a year following their diagnosis.\u003Cbr>Key Words: cancer ■ epidemiology ■ prediction model ■ stroke ■ thromboembolism |  |\n| --- | --- |\n| Cancer is an increasingly recognized risk factor for\u003Cbr>ischemic stroke.1,2 Approximately 10% of hospitalized patients with ischemic stroke have previously diagnosed cancer, and this number is expected to rise as more people are living with and surviving cancer due to improvements in cancer screening programs, diagnostic capabilities, and therapeutic options. However, arterial thromboembolism including stroke | has been relatively understudied in the cancer population compared with its venous counterpart. While risk stratification tools such as the Khorana score can identify patients with cancer at high risk of venous thromboembolism (VTE) and guide the use of prophylactic anticoagulation based on randomized trials, the Khorana score has poor discrimination for predicting arterial and venous thromboembolism combined.3–7 |\n\nCorrespondence to: Deborah Siegal, MD, MSc, Ottawa Blood Diseases Centre, The Ottawa Hospital, Department of Medicine, University of Ottawa, 501  \nSmyth Road, Box 201A, Ottawa, Ontario, Canada K2H 8L6 . Email: [dsiegal@toh.ca](dsiegal@toh.ca)  \n*D. Siegal and R. Sutradhar are co-senior authors.  \nThis article was sent to Michelle H. Leppert, MD, MBA Associate Editor, for review by expert referees, editorial decision, and final disposition.  \nSupplemental Material is available at [https://www.ahajournals.org/doi/suppl/10.1161/JAHA.125.045631](https://www.ahajournals.org/doi/suppl/10.1161/JAHA.125.045631)[ ](https://www.ahajournals.org/doi/suppl/10.1161/JAHA.125.045631)[For Sources of Funding and Disclosures](For Sources of Funding and Disclosures) , see page 9.  \n© 2026 The Author(s) . Published on behalf of th","cbCaihXVhS9L90e9","https://ap.wps.com/l/cbCaihXVhS9L90e9","pdf",470496,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Clinical Perspective\n## What Is New?\n## Clinical Implications\n# Nonstandard Abbreviations and Acronyms","[{\"question\":\"Why was the PRIME tool developed for patients with newly diagnosed cancer?\",\"answer\":\"The risk of ischemic stroke is highest in the first year after a new cancer diagnosis, yet no existing tools could identify patients at highest risk. PRIME was created to fill this gap.\"},{\"question\":\"How was the prediction model derived and validated?\",\"answer\":\"Researchers conducted a population-based retrospective cohort study and randomly assigned patients to prediction model derivation (60%) or validation (40%). Performance was assessed using discrimination (C statistic) and calibration plots.\"},{\"question\":\"What performance did PRIME show for predicting 1-year ischemic stroke?\",\"answer\":\"The model showed good discrimination with a C statistic of 0.73 and was well calibrated, with points following the desired 45-degree line.\"}]","Development and Validation of the Predicting Risk of Ischemic Stroke in Malignancy Estimation Tool | PDF",1790126076,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc2c919e26bd0103571cf5dfb7e38e63.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe88da0f2c9212ff5f8827477001fe66.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b21134f5448de1b98b6480dda34fabb.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1310cae259f3d24e952fe9f21d45a75d.webp",980,1287]